Dr. Ian Lipkin is raising money for a potentially ground-breaking study on the microbiome in ME/CFS. If successful, it could provide an explanation for the chronic immune activation found in ME/CFS patients. It could also lead to effective treatments. The total cost of the study is $1 million. Because NIH has not funded the research, Dr. Lipkin is relying on independent sources for support. You can donate HERE.
To read more about Dr. Lipkin’s study, click HERE.